Advertisement

The Scientist

» FDA and evolution

Most Recent

image: Conserved Chromatin?

Conserved Chromatin?

By | December 10, 2012

Archaea packages DNA around histones in a similar way to eukaryotes, suggesting that fitting a large genome into a small space was not the original role of chromatin.

2 Comments

image: Drug Approvals Up

Drug Approvals Up

By | December 7, 2012

The total number of new drugs approved this year ties last year for the highest since 2004, suggesting that the pharmaceutical industry is recovering.  

0 Comments

image: Hurry Up, FDA

Hurry Up, FDA

By | December 6, 2012

The US Food and Drug Administration is taking steps to get new devices on the market sooner—and antibiotics may be next.

0 Comments

image: Call for Conflict Hub

Call for Conflict Hub

By | December 3, 2012

Biomedical groups propose a simplified system for the disclosure of potential conflicts of interests.

0 Comments

image: Speaking of Science

Speaking of Science

By | December 1, 2012

December 2012's selection of notable quotes

0 Comments

image: The Plastic Genome

The Plastic Genome

By | December 1, 2012

The poxvirus stockpiles genes when it needs to adapt.

1 Comment

image: Charles Darwin for Congress

Charles Darwin for Congress

By | November 13, 2012

Nominated as a write-in candidate as a protest against the anti-science incumbent, famed naturalist Charles Darwin won 4,000 congressional votes in a Georgia county.

1 Comment

image: Book Excerpt from The Science of Consequences

Book Excerpt from The Science of Consequences

By | November 1, 2012

In Chapter 2, "Consequences and Evolution: The Cause That Works Backwards," author Susan M. Schneider places evolutionary theory in terms of the science of consequences.

1 Comment

image: Moss Harbors Foreign Genes

Moss Harbors Foreign Genes

By | October 23, 2012

Genes from fungi, bacteria, and viruses may have helped mosses and other plants to colonize the land.

2 Comments

image: Uncloaking Clinical Trials

Uncloaking Clinical Trials

By | October 17, 2012

Glaxo­SmithKline will share long-sought, raw trial data—but access will be tightly controlled.  

0 Comments

Follow The Scientist

icon-facebook icon-linkedin icon-twitter icon-vimeo icon-youtube
Advertisement

Stay Connected with The Scientist

  • icon-facebook The Scientist Magazine
  • icon-facebook The Scientist Careers
  • icon-facebook Neuroscience Research Techniques
  • icon-facebook Genetic Research Techniques
  • icon-facebook Cell Culture Techniques
  • icon-facebook Microbiology and Immunology
  • icon-facebook Cancer Research and Technology
  • icon-facebook Stem Cell and Regenerative Science
Advertisement
Advertisement
Life Technologies